Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis
ConditionAxial Spondyloarthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorWestern Health and Social Care Trust
About this trial
This is an observational study using Inertial Measurement Unit (IMU) sensors to measure the effects of biological therapy on spinal mobility and function in axial spondyloarthritis. Participants will undergo MRI scans before and after therapy in parallel to the sensor tests to establish correlation between changes in inflammatory signs and changes in spinal mobility.
Eligibility criteria
Qualifiers
Diagnosis of axial spondyloarthritis fulfilling ASAS classification criteria.
Age ≥18 years old and <80 years.
Fulfilment of local criteria for biologic therapy for axSpA.
The subjects should be able to read, write, understand and complete study questionnaires.
Disqualifiers
Safety contra-indication for biologic drug therapy.
Severely restricted hip movement (less than 20 degrees rotation in either hip).
History of previous clinical (symptomatic) vertebral fracture.
History of previous spinal surgery.
Trial design
Treatments tested in this trial
- IMU sensor test
Treatment groups
No treatment groups listed
Sponsors and collaborators
Western Health and Social Care Trust
Lead sponsor
University of Ulster
Collaborator
Source ClinicalTrials.gov